Screen Reader Mode Icon
  • Deutsch (Deutschland)
  • English
  • Español (España)
  • Français (France)
  • Italiano (Italia)

Dear Participant,

Cancer is an extremely complex disease. Personalised treatment decisions are key to improving the management of cancer patients. Genomic testing is an example of current progress in this area. However, awareness and understanding of genomics and genomic testing are still in the early stages, particularly in the patient community. 

This survey is part of the myC (my Cancer my Concern) initiative, led by the organisation Cancer Patients Europe (CPE). It aims to raise awareness of the benefits and value of genomic testing in cancer. By participating in this survey, you can make a difference for cancer patients across Europe.

It will take less than 10 minutes to complete the survey. The questions have been designed to be short and user-friendly. 

For more information about your data privacy, please read our privacy policy.

Thank you for your valued participation.

Question Title

* 1. Please tick the box below before starting the survey.